Company / Revenue
Moderna Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.9B
FY2025
5-year range
$60.0M / $6.8B
FY2021-FY2025
Trend
-39.9%
vs FY2024
Sector context
#32 of 155
Health Care
What the data says
Moderna's revenue of $1.9B is higher than 79% of companies in the Health Care sector (FY2025). Revenue has fluctuated over the past 10 years, ranging from $60M in FY2021 to $6.8B in FY2023.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +19.3%. Top quartile in the Health Care sector.
Declined from $6.8B to $1.9B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +34.3%
- 5-Year CAGR
- +19.3%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 155This company $1.9B Sector average $4.5B
▼
-56.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +19.3%, indicating consistent growth.
- In FY2025, revenue decreased 39.9% year-over-year.
- Ranks #32 out of 155 companies in the Health Care sector.
- Peak revenue was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | -39.9% |
| FY2024 | $3.2B | -52.7% |
| FY2023 | $6.8B | +752.8% |
| FY2022 | $803.0M | +1238.3% |
| FY2021 | $60.0M | -92.5% |
| FY2020 | $803.0M | +1238.3% |
| FY2019 | $60.0M | -55.6% |
| FY2018 | $135.1M | -34.4% |
| FY2017 | $205.8M | +89.9% |
| FY2016 | $108.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026